Consider the following medical report that includes the patient's historical health records. Use it to predict the disease that the patient is high likely exposed to. 

 Medical Report: allergies: percocet / aspirin / tylenol / morphine attending: chief complaint: end stage renal disease admitted for kidney transplantation major surgical or invasive procedure: - deceased donor renal transplant - cardioversion history of present illness: patient is a 69 year old female with esrd htn maintained on peritoneal dialysis for the past 3 years. her last hemodialysis was the night prior to presenting for transplant operation. at the time of admission patient had no active issues, she was afebrile, had no nausea or vomiting. patient had no recent hospitalizations. past medical history: - esrd htn - partial colectomy for colonic polyps - thyroid resection for benign disease - ventral hernia repair - ichemic left leg s/p common femoral and profunda endarterectomy, sfa embolectomy, four compartment fasciotomies social history: - married, lives at a farm house with her husband - has 2 daughters and 1 son (one daughter and a son lives within a block of the patient) family history: noncontributory physical exam: gen: wd/wa, nad, aoox3 cv: rrr, nl s1, s2, no murmur appreciated pulm: ctab abdomen: soft/nt/nd, well healed midline scar, pd site c/d/i, post-tranplant incision is c/d/i, there is no edema, no erythema, no drainage extremities: no c/c, 1+ pitting edema left le, 4 incision fasciotomy scars well healed on left foot pulses: 2+ femoral b/l, 1+ right dp/pt, 2+ left dp/pt neuro: cn ii - xii intact pertinent results: admission : 10:32am glucose-135* urea n-52* creat-8.2* sodium-141 potassium-4.2 chloride-102 total co2-28 anion gap-15 10:32am calcium-8.5 phosphate-3.0 magnesium-1.4* 10:32am wbc-4.8 rbc-3.25* hgb-10.5* hct-32.7* mcv-101* mch-32.2* mchc-32.1 rdw-16.3* 10:32am plt count-286 09:57am type-art po2-209* pco2-40 ph-7.42 total co2-27 base xs-1 intubated-intubated vent-controlled comments-or 16 09:57am glucose-102 lactate-1.7 na+-136 k+-3.7 cl--99* 09:57am hgb-9.8* calchct-29 09:57am freeca-1.09* 09:00am type-art po2-170* pco2-35 ph-7.50* total co2-28 base xs-4 intubated-intubated vent-controlled 09:00am glucose-95 lactate-1.8 na+-135 k+-3.4* cl--99* 09:00am hgb-9.3* calchct-28 09:00am freeca-0.89* 03:16am urea n-55* creat-9.1* sodium-140 potassium-5.6* chloride-98 total co2-28 anion gap-20 03:16am estgfr-using this 03:16am alt(sgpt)-18 ast(sgot)-54* 03:16am albumin-3.5 calcium-7.8* phosphate-3.3 magnesium-1.7 03:16am wbc-8.1 rbc-3.56* hgb-11.1* hct-35.9*# mcv-101* mch-31.0 mchc-30.8* rdw-15.4 03:16am plt count-354 03:16am plt count-354 discharge: 05:20am blood wbc-6.1 rbc-3.20* hgb-9.9* hct-31.6* mcv-99* mch-31.0 mchc-31.4 rdw-15.9* plt ct-315 05:20am blood pt-14.9* ptt-25.9 inr(pt)-1.3* 05:20am blood glucose-95 urean-21* creat-1.6* na-136 k-4.4 cl-105 hco3-22 angap-13 03:41pm blood ck(cpk)-27 05:44am blood alt-5 ast-14 ck(cpk)-23* alkphos-116 totbili-0.6 05:20am blood calcium-9.6 phos-2.4* mg-1.4* 06:01am blood tsh-0.52 05:20am blood tacrofk-10.5 imaging: ecg sinus rhythm. first degree a-v block. premature atrial contractions. non-specific st-t wave changes. compared to the previous tracing of qrs changes in leads v2-v3 could be due to lead placement. ecg narrow complex tachycardia is sprobably due to sinus tachycardia with a long p-r interval. diffuse st-t wave changes are likely due to the rate. compared to the previous tracing of atrial premature beats are not seen. the overall rate has increased. the st-t wave changes are now more prominent, though they likely reflect repolarization abnormalities from a fast heart rate. cxr impression: no evidence of failure. no cardiomegaly. portable tte impression: normal regional and global biventricular systolic function. mild mitral regurgitation. brief hospital course: hd1 patient presented to the hospital and had a kideny transplant done on the day of admission. she tolerated surgery well, her post-operative course in the pacu was uneventful and she was transferred to the floor in stable condition. her pain was controlled with pca dilaudid. hd2 patient was stable. her urine output increased very shortly after the operation; she made about 400ml of urine in the initial 12 hours post-op and her creatinine decreased from 8.2 to 6.8. her jp output was replaced with 1cc per 1cc replacement. she also recieved maintainence iv fluids. she was started on the sips of clears and continued to have pca in place, yet had a minimal pain requirement. her anticoagulation was resumed, she received coumadin 2mg. there were no cardiovascular or pulmonary issues. hd3 patient's creatinine decreased further to 3.7. her urine output increased to over 2200ml in 24 hours. her jp output was now replaced with 1/2cc per 1cc, the maintaince iv fluids continued. patient developed chest pain and shortness of breath. the work up was done, she had chest x-ray, ekg and cardiac enzymes sent out, which were all negative for any sign of cardiac ischemia. her blood pressure increased a little but during the episode and she was tachycardic to 100, yet never experienced any oxygen desaturation. in the afternoon, patient developed cardiac arrythmia, atrial flutter. she recieved metoprolol iv pushes, to which she did not respond. her blood pressure and heart rate remained elevated, her oxygen saturation was close tp 100% on room air, she was tachypnic. cardiology was consulted. the recommendation was to increase metoprolol to 50mg , tte was ordered for next day and the plan was to cardiovert the patient the next morning. she was started on wellbutrin 75 mg . she recieved coumadin 2mg. hd4 her urine output was over 2l with still downtreanding creatinine level. her cardiovascular status has not changed and the cardioversion was attempted unsuccesfully. her medical managment was changed to metoprolol 75mg tid after cardioversion. her tachypnea in 100s and hypertension in 150s/90s continued. her wellbutrin was increased to her home dose of 150mg . she did not recieve her coumadin as she was supratherapeutic. she tolerated regular diet. the foley was removed. hd5 patient's creatinine decreased further, her urine output was over 2l for the past 24 hours. she continued to be tachycardic now in 120- 150s and hypertensive. the change was made by cardiology and she was started on metoprolol 100mg tid and sotalol 40mg once daily. later in the afternoon, electrophysiology fellow recommended that we stop the sotalol and start digoxin. she recieved one dose of digoxin that day. in the late evening patient was unchanged and develop shortness of breath, her heart rate was in 130-150s, bp was 160-170s/90-100s. she was transferred to icu and started on amiodarone taper, her metoprolol was increased to 150mg tid. her coumadin was held. patient tolerated regular diet. hd6 patient's urine output has dropped, but she was still making urine and her creatinine was downward trending. her arrythmia resolved in the afternoon, yet she remained tachycardic and hypertensive. she recieved 24 hour iv amiodarone taper and was subsequently switched to an oral amiodarone. her chest pain has resolved, all the workup was negative for an ischemic event. she continued to tolerate regular diet. hd7 patient's urine output increased again and her creatinine was down to 1.6. norvasc and hydralazine were added and adequate blood pressure control was achieved. patient had no chest pain and continued to be in sinus rythm. she was transferred from the icu to the floor. she tolerated regular diet. she recieved 0.5mg of coumadin. hd8 patient's creatinine is still improving with good urine output. there were no cardiac issues at this time. the blood pressure was controlled in 140-150s/80-90s range. she tolerated regular diet. throughout her hospitalization patient was afebrile. she did not have any infections and recieved no antibiotics. she denied any nausea, vomiting, diarrhea, constipation, chest pain, shortness of breath or pain at the time of dicharge. she was discharged with the jp drain in place. medications on admission: alendronate 35 qmonth, amlodipine 10', atenolol 25', nephrocaps 1', bupropion 150", calcium acetate 1334 qidwmhs, sensipar 30', epo, nexium 40', lactulose 30", lisinopril 10', kcl 20', simvastatin 20', renagel 800'''', sucralfate 2''', coumadin 2' on mon and fri, 1' twthssun discharge medications: 1. hydralazine 10 mg tablet sig: two (2) tablet po every eight (8) hours. disp:*30 tablet(s)* refills:*1* 2. amlodipine 5 mg tablet sig: two (2) tablet po daily (daily). disp:*60 tablet(s)* refills:*2* 3. tacrolimus 1 mg capsule sig: two (2) capsule po q12h (every 12 hours). disp:*60 capsule(s)* refills:*2* 4. trimethoprim-sulfamethoxazole 80-400 mg tablet sig: one (1) tablet po daily (daily). 5. nystatin 100,000 unit/ml suspension sig: five (5) ml po qid (4 times a day). 6. mycophenolate mofetil 500 mg tablet sig: two (2) tablet po bid (2 times a day). 7. valganciclovir 450 mg tablet sig: one (1) tablet po daily (daily). 8. pantoprazole 40 mg tablet, delayed release (e.c.) sig: one (1) tablet, delayed release (e.c.) po q12h (every 12 hours). disp:*60 tablet, delayed release (e.c.)(s)* refills:*2* 9. hydromorphone 2 mg tablet sig: one (1) tablet po every six (6) hours as needed for pain. disp:*60 tablet(s)* refills:*0* 10. bupropion hcl 75 mg tablet sig: two (2) tablet po bid (2 times a day). 11. metoprolol tartrate 50 mg tablet sig: three (3) tablet po tid (3 times a day). disp:*270 tablet(s)* refills:*2* 12. coumadin 1 mg tablet sig: one (1) tablet po once a day. disp:*30 tablet(s)* refills:*2* 13. docusate sodium 100 mg capsule sig: one (1) capsule po bid (2 times a day). 14. amiodarone 200 mg tablet sig: two (2) tablet po bid (2 times a day) for 2 weeks: take 400mg twice daily for 2 weeks, then take 200mg twice daily for 4 weeks . disp:*56 tablet(s)* refills:*0* 15. amiodarone 200 mg tablet sig: one (1) tablet po twice a day for 4 weeks. disp:*56 tablet(s)* refills:*0* 16. alendronate 35 mg tablet sig: one (1) tablet po once a month. discharge disposition: home with service facility: vna discharge diagnosis: end stage renal disease s/p deceased donor renal transplant new onset cardiac arrythmia/ atrial flutter discharge condition: stable discharge instructions: you are going home with your immunosupression medications. please call transplant coordinator with any questions you may have regarding the medications or any other concerns/questions. the jp drain has not yet been removed, as it continues to drain fair amount of fluid. the vna services will visit you at home and help with the jp drain managment. dr. will see you in clinic and will determine when the jp will come out. it will be removed at the clinic. you may shower with the drain in place. you may eat regular diet, but ideally low in sodium and potassium to protect your new kidney. you may resume your previous activities as tolerated, however no heavy lifting for at least a month. you may keep the incision uncovered. you may shower with the staples in place. staples will be removed at the clinic in a few weeks. please monitor your output. if it drops significantly, please call the transplant coordinator or come to the emergency room. also, if you develop any drainage from your incision, fever, nausea, vomiting or significant pain, shortness of breath, chest pain or palpitations please call the coordinator or go to emergency room. followup instructions: provider: , md phone: date/time: 1:40 provider: , transplant social work date/time: 3:00 provider: , md phone: date/time: 3:20 provider: , , md phone: date/time: 10:30 procedure: atrial cardioversion other kidney transplantation other operations on lacrimal gland transplant from cadaver diagnoses: end stage renal disease cardiac complications, not elsewhere classified atrial fibrillation atrial flutter hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease 

Answer: The patient is high likely exposed to